v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net revenues $ 39 $ 46
Costs and operating expenses:    
Cost of goods sold 313 226
Research and development 3,642 2,748
Sales and marketing 164 358
General and administrative 1,879 1,821
Total costs and operating expenses 5,998 5,153
Operating loss (5,959) (5,107)
Other income (expense):    
Change in fair value of forward purchase agreement warrant liability (13) 421
Loss on offering and change in fair value of private warrant liability 2,005
Change in fair value of publicly traded warrant liability (390) 194
Interest expense (related party) (495)
Other income (expense), net 6 (11)
Total other income (expense), net 1,608 109
Net loss (4,351) (4,998)
Cumulative preferred dividends (1,350) (1,238)
Net loss attributable to common stockholders, basic (5,701) (6,236)
Net loss attributable to common stockholders, diluted $ (5,701) $ (6,236)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.08) $ (0.29)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.08) $ (0.29)
Weighted-average Class A Common Stock and pre-funded warrants outstanding, basic (in Shares) 68,934,960 21,326,609
Weighted-average Class A Common Stock and pre-funded warrants outstanding, diluted (in Shares) 68,934,960 21,326,609
Other comprehensive (loss) income:    
Foreign currency translation adjustment $ (1) $ 6
Other comprehensive (loss) income (1) 6
Comprehensive loss $ (4,352) $ (4,992)